Treatment with rFVIIaresulted in stabilization and regression of the hematoma.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Intracranial hemorrhage is considered the most common cause of death innewborns with congenital factor VII (FVII) deficiency.
📊
Temel Bulgular & Veri:We describe our experience about thetreatment of intracranial hemorrhage in a newborn with congenital FVIIdeficiency and emphasize the importance of imaging in asymptomatic patients.She presented with ecchymoses on her skin, no other pathological clinical signs,prolonged PT, normal PTT and FVII activity of 2%.
💡
Sonuç & Katkı:Treatment with rFVIIaresulted in stabilization and regression of the hematoma.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
Intracranial hemorrhage is considered the most common cause of death innewborns with congenital factor VII (FVII) deficiency. Recombinant activatedFVII (rFVIIa) provides specific replacement therapy, however there is limitedexperience with its neonatal use. We describe our experience about thetreatment of intracranial hemorrhage in a newborn with congenital FVIIdeficiency and emphasize the importance of imaging in asymptomatic patients.She presented with ecchymoses on her skin, no other pathological clinical signs,prolonged PT, normal PTT and FVII activity of 2%. Intracranial hemorrhagewas diagnosed while screening for internal bleedings. Treatment with rFVIIaresulted in stabilization and regression of the hematoma.
🔖
Bu Makaleye Atıf Yap
İNCE, Z., BULUT, Ö., AKSAKAL, M. T., ÜNÜVAR, A., DEVECİOĞLU, Ö., ÇOBAN, A. (2018). Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII. Turkish Journal of Pediatrics, Cilt: 60 - Sayı: 5, 562–565. https://ajindex.com/articles/412125
Farah RA, Hamod D, Melick N, Giansily-Blaizot M, Sallah S. Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency. J Thromb Haemost 2007; 5: 433-434
Mariani G, Herrmann FH, Dolce A, et al; International Factor VII Deficiency Study Group. Clinical phenotypes and factor VII genotype in congenital factor VII deficiency. Thromb Haemost 2005; 93: 481-487
Williams WJ, Beutler E, Erslev AJ and Lichtman MA. Hematology (3rd ed), New York: McGraw-Hill, 1983
Cooper DN, Millar DS, Wacey A, Banner DW, Tuddenham EG. Inherited factor VII deficiency: Molecular genetics and pathophysiology. Thromb Haemost 1997; 78: 151-160
Ingerslev J, Kristensen HL. Clinical picture and treatment strategies in factor VII deficiency. Haemophilia 1998; 4: 689-696
Charpiat B, Laporte S, Mismetti P, Debize G, Ducerf C. Perioperative pharmacokinetics of factor VII concentrate during liver surgery in a patient with congenital factor VII deficiency: An individual mathematical model. Blood Coagul Fibrinolysis 2002; 13: 457-460
Wong WY, Huang WC, Miller R, McGinty K, Whisnant JK. Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency. Haemophilia 2000; 6: 50-54
Mariani G, Testa MG, Di Paolantonio T, Molskov Bech R, Hedner U. Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies. Vox Sang 1999; 77: 131-136
Mathew P, Young G. Recombinant factor VIIa in paediatric bleeding disorders -a 2006 review. Haemophilia 2006; 12: 457-472
Brenner B, Wiis J. Experience with recombinantactivated factor VII in 30 patients with congenital factor VII deficiency. Hematology 2007; 12: 55-62
Greisen G, Andreasen RB. Recombinant factor VIIa in preterm neonates with prolonged prothrombin time. Blood Coagul Fibrinolysis 2003; 14: 117-120
Brady KM, Easley RB, Tobias JD. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Pediatr Anaesth 2006; 16: 1042-1046
Olomu N, Kulkarni R, Manco-Johnson M. Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. J Perinatol 2002; 22: 672-674
Karimi M, Shafieian R. Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency. Haemophilia 2008; 14: 851-852